UBS O'Connor’s Axogen AXGN Stock Holding History

UBS O'Connor’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-50,000	Closed	-$23.8K	–	296
2025 Q2	$23.8K	Buy	+50,000	New	+$655K	﹤0.01%	336

Other funds holding AXGN

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

UBS O'Connor's AXGN Position: Q3 2025 in Review

UBS O'Connor sold out of Axogen (AXGN) in Q3 2025, closing a stake of 81,429 shares — an estimated $884K sold.

UBS O'Connor first reported a position in AXGN in Q1 2022 and held it in 14 quarters. The position peaked at $2.69M in Q3 2022. 171 funds tracked by Wall St. Rank hold AXGN as of Q3 2025.

UBS O'Connor reported no remaining Axogen position as of Q3 2025 after selling out during the quarter.
UBS O'Connor sold 81,429 Axogen shares in Q3 2025, an estimated $884K.
UBS O'Connor first reported a position in Axogen in Q1 2022 and held it in 14 quarters.
UBS O'Connor's Axogen position peaked at $2.69M in Q3 2022.
171 funds tracked by Wall St. Rank held Axogen as of Q3 2025.

Based on UBS O'Connor's 13F filing for Q3 2025, filed 14 Nov 2025.